Energy and Infrastructure Transition Analyst Lewis holds a virtual meeting with management on November 22 hosted by BTIG. Don't Miss out on Research Tools: Discover the latest stocks recommended by ...

Fintel reports that on November 19, 2024, BTIG upgraded their outlook for Aclaris Therapeutics (NasdaqGS:ACRS) from Neutral ...

BTIG analyst Marvin Fong raised the firm’s price target on RealReal (REAL) to $5.50 from $4 and keeps a Buy rating on the shares. The firm ...

Donald Trump has been somewhat cagey about his economic plans — especially tariffs — since voters elected him president. That ...

Shares of Aclaris Therapeutics (NASDAQ:ACRS) soared 60% Tuesday, the day after the company announced it was licensing two ...

Simulations Plus, Inc. ("Simulations Plus"), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, ...

“Donald Trump cares about independent validators. And the biggest independent validator of his success is the market. It’s a ...

Chris Fritz, Senior Vice President of Financial Planning and Analysis at Tenable, is scheduled to attend the BTIG Virtual Software Forum. Vintz is also scheduled to attend the Barclays Global ...

Yet there is another force that could deter Trump from some of his most extreme instincts: the $50 trillion US stock market.

In recent trading, HashiCorp Inc (HCP) stock price has shown some volatility, fluctuating -1.41% over the last five trades and -0.41% over the past 30 trades. This represents a notable shift from ...

On Monday, Exelixis Inc (EXEL) stock saw a modest uptick, ending the day at $34.52 which represents a slight increase of $0.07 or 0.20% from the prior close of $34.45. The stock opened at $34.15 and ...

Shares of Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) have earned an average recommendation of “Buy” from the ...